Literature DB >> 11802309

n-3 fatty acids and the immune system in autoimmunity.

David Ergas1, Eran Eilat, Shlomo Mendlovic, Zeev M Sthoeger.   

Abstract

In short-term studies, both in animals and in humans, fish oil seems to exert anti-inflammatory effects. However, these effects may vanish during long-term treatment. There is a possibility that in autoimmune diseases, supplementation of dietary n-3 fatty acids might lead to a decrease in the number of autoreactive T cells via apoptosis, as demonstrated in (NZBXNZW) F1 lupus mice [40]. Thus, the "fade away" effect might be due to regrowth of pathogenic autoreactive cells. In animal models of autoimmune diseases, diets high in n-3 fatty acids from fish oil increase survival and reduce disease severity in spontaneous autoantibody-mediated disease, while n-6 linoleic acid-rich diets appear to increase disease severity. The situation in human disease is probably more complex. Some of the discrepancy between studies can be attributed to methodologic problems. The effect of fish oil is dose, time and disease-dependent. Since the anti-inflammatory effects depend on the balance between n-3 and n-6 fatty acids, the relative proportion of EPA and DHA and possibly co-treatment with dietary vitamin E, the dose/effect ratio may vary between individuals. Furthermore, some animal studies demonstrating efficacy used very high doses that may be incompatible with human consumption. It seems that fish oil is only mildly effective in acute inflammation. In those chronic inflammatory disorders where it was found to be effective, several weeks are necessary to exhibit results. Yet, this mild anti-inflammatory effect, possibly through downregulation of pro-inflammatory cytokine production, leads to striking therapeutic improvement in critically ill patients. Fish oil supplementation seems advantageous especially in acute and chronic disorders where inappropriate activation of the immune system occurs. Fish oil has only a mild effect on active inflammation of diseases such as rheumatoid arthritis, SLE and Crohn's disease, but it could prevent relapse (in some of the studies). In diseases where the inflammation is mild, such as IgA nephropathy, fish oil may slow or even prevent disease progression. The above could explain the observation in some populations of a decreased incidence of inflammatory and autoimmune diseases [3], since the constant consumption of n-3 fatty acids could suppress any autoreactive (or hyper-reactive) T cells. However, if there is already an existing disease, increased consumption might not be beneficial over a long period. Therefore, the use of n-3 fatty acids can be recommended to the general healthy population, not only to prevent atherosclerosis but possibly also to reduce the risk of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802309

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  11 in total

Review 1.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

2.  Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes.

Authors:  C Ricordi; M Clare-Salzler; M Infante; C Baggerly; J Aliano; S McDonnell; S Chritton
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2019-08-28

3.  Inhibitory activities of omega-3 Fatty acids and traditional african remedies on keloid fibroblasts.

Authors:  Peter B Olaitan; I-Ping Chen; James E C Norris; Richard Feinn; Odunayo M Oluwatosin; Ernst J Reichenberger
Journal:  Wounds       Date:  2011-04       Impact factor: 1.546

Review 4.  Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.

Authors:  Paola Bozzatello; Elena Brignolo; Elisa De Grandi; Silvio Bellino
Journal:  J Clin Med       Date:  2016-07-27       Impact factor: 4.241

Review 5.  Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).

Authors:  Tobias Banaschewski; Brendan Belsham; Michael H Bloch; Maite Ferrin; Mats Johnson; James Kustow; Sarah Robinson; Alessandro Zuddas
Journal:  Nutr Health       Date:  2018-06-19

6.  Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program.

Authors:  Prae Charoenwoodhipong; Sioban D Harlow; Wendy Marder; Afton L Hassett; W Joseph McCune; Caroline Gordon; Charles G Helmick; Kamil E Barbour; Lu Wang; Peter Mancuso; Emily C Somers; Suzanna M Zick
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07       Impact factor: 4.794

7.  Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?

Authors:  Paola Bozzatello; Paola Rocca; Emanuela Mantelli; Silvio Bellino
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

Review 8.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.

Authors:  Raffi Lev-Tzion; Anne Marie Griffiths; Oren Leder; Dan Turner
Journal:  Cochrane Database Syst Rev       Date:  2014-02-28

9.  Potential role of dietary lipids in the prophylaxis of some clinical conditions.

Authors:  Urvashi Bhagat; Undurti N Das
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

Review 10.  Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review.

Authors:  Francesca Penagini; Dario Dilillo; Barbara Borsani; Lucia Cococcioni; Erica Galli; Giorgio Bedogni; Giovanna Zuin; Gian Vincenzo Zuccotti
Journal:  Nutrients       Date:  2016-06-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.